Developer docs
API playgroundTry for free, no card

Search company profiles

Ocumetra

Full company profile

uuid000gs9x

Namestring
Ocumetra
Legal namestring
Ocumetra Ltd.
Websiteurl
ocumetra.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Ocumetra is a Dublin-based digital health company that develops the mEYE Suite, a web-based software platform for evidence-based myopia management in children. The platform is built around a proprietary, population-representative database of over one million data points on refractive development, axial length, and myopia-related disease risk, accumulated over eight years and incorporating multi-ethnic data. Core products include mEYE Guide (parent-facing communication reports with QR sharing), mEYE Gauge (axial length estimation with a 95% prediction range for clinicians without biometry equipment), mEYE Score (treatment monitoring), and the forthcoming mEYE Map. An API enables integration with EHR/EMR systems and biometric devices, with Topcon Healthcare named as an integration partner. The platform is web-based, GDPR-compliant, ISO 27001:2022 certified, and available in seven languages across markets including Ireland, the UK, North America, Australia, and New Zealand.

Ocumetra generates revenue primarily through recurring subscriptions to mEYE Suite, sold on monthly or annual cycles with a one-month free trial and tiered pricing for independent practices (1-4 clinics), growing groups (5-15), networks (15-50), and large enterprises (50+ clinics). A second revenue stream comes from bespoke industry solutions and data analytics services provided to eyecare product companies such as CooperVision, Dopavision, Sightglass, and Safilens, including clinical trial support and marketing tools. Academic partnerships offer free platform access to optometry/ophthalmology students at universities including TU Dublin, University of Bradford, and Nova Southeastern, serving as a long-term adoption pipeline. Go-to-market combines product-led growth (self-serve trial, multi-language web platform) with channel partnerships through a structured four-track program spanning clinical, industry, academic, and integration partners.

The company is co-founded and led by Professor James Loughman (CEO, PhD) and Professor Ian Flitcroft (CIO, D.Phil FRCOphth), both recognized myopia researchers, supported by a management team with regulatory, software development, clinical data analysis, and strategic growth functions. The board includes representatives from Ocuco, Furthr VC, and THINC Ventures (Topcon Healthcare's CVC), reflecting a mix of strategic corporate and venture capital backing. Headcount is reported at 11-50 employees.

Short descriptiontext

Ocumetra is a Dublin-based digital health company that provides the mEYE Suite, a web-based myopia management software platform serving eyecare professionals, optical networks, and eyecare product companies with predictive analytics, parent communication tools, and EHR/biometric device integrations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDublin, Ireland
HQ citystring
Dublin
HQ countrystring
Ireland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
myopia management software, ophthalmic clinical analytics, axial length estimation, eye care practice software, pediatric vision analytics
NAICS code2 codes
  • Custom Computer Programming Services541511
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Myopia Management Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Software Subscription (mEYE Guide)
TypeSubscription Recurring
Description

Monthly or annual subscription service for mEYE Guide patient communication platform. Free 1-month trial available. Annual subscription includes two months free (preferred option). Easily cancellable subscriptions. Revenue is subscription-based recurring with monthly or annual billing cycles.

ocumetra.com
2Bundled Platform Access
TypeSubscription Recurring
Description

Annual bundle offering provides access to multiple tools (mEYE Guide, mEYE Gauge) with two months free, offering better value than monthly subscriptions. mEYE Gauge is included free with mEYE Guide subscription.

ocumetra.com
3Bespoke Industry Solutions
TypeSubscription Recurring
Description

Custom clinical tools, data analytics, and integration services for industry partners seeking to enhance myopia management outcomes. Revenue generated through bespoke partnership agreements with product companies requiring custom tools including myopia and presbyopia simulation tools.

ocumetra.com
4Enterprise/Group Subscriptions
TypeSubscription Recurring
Description

Tiered subscription models targeting different practice sizes from independent innovators (1-4 clinics) to energetic enterprises (50+ clinics), with pricing varying by organization scale. Payments processed via Stripe supporting credit cards, debit cards, digital wallets, and regional payment methods.

mcp.ocumetra.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others
Pricing details3 tiers
1Free 1-month trial with access to mEYE Guide and mEYE Gauge
ModelFreemiumBilling cadenceMonthly
Notes

Free trial period allows eyecare professionals to experience the platform. mEYE Gauge is provided free with mEYE Guide trial. Platform uses Stripe for payment processing supporting Visa, Mastercard, American Express, Discover, JCB, Diners Club, Apple Pay, Google Pay, and regional methods like Alipay, WeChat Pay, SEPA Direct Debit.

ocumetra.com
2Monthly subscription after free trial
ModelSubscriptionBilling cadenceMonthly
Notes

Easily cancellable monthly subscription service. Quote-based pricing not publicly disclosed on website. The company emphasizes tools deliver tremendous value with average 75% increase in myopia management treatment uptake and retention.

ocumetra.com
3Annual bundle subscription with 2 months free
ModelSubscriptionBilling cadenceAnnual
Notes

Preferred option offering additional two months free use of tools. Single annual payment for easier accounting. Requires cancellation at least one month before scheduled end date of annual subscription.

ocumetra.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1mEYE Suite
Description

An all-in-one myopia management software platform featuring modules for patient communication, axial length estimation, and clinical scoring.

ocumetra.com
+4 more records
Core offering1 text field

Ocumetra sells the mEYE Suite, a web-based myopia management software platform for eyecare professionals that combines parent communication tools, axial length estimation, treatment monitoring, and centile-based clinical scoring, powered by a proprietary database of over one million patient records and machine learning-based predictive modeling. The company also offers an API for EHR/EMR and biometric device integration and a partnership program delivering bespoke clinical tools, data analytics, and integration services to industry, academic, and clinical partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 75% average increase in myopia management treatment uptake and retention in practices using Ocumetra tools
+3 more records
Product overview1 text field

Ocumetra offers the mEYE Suite as its core all-in-one myopia management software platform. The suite consists of interconnected modules: mEYE Guide for parent communication, mEYE Gauge for axial length estimation (free with Guide subscription), mEYE Score for treatment monitoring, and the forthcoming mEYE Map for refractive context. Additional tools include centile charts and a vision simulator. The platform is web-based and accessible on any modern browser (phone, tablet, or desktop), available globally in English, French, Spanish, Portuguese, Hebrew, Russian, and Italian. Ocumetra also provides an API for EHR/EMR and biometric device integrations, alongside a partnership program offering bespoke clinical tools, data analytics, and integration services for clinical, industry, integration, and academic partners.

Product and service6 records
1mEYE Suite
CategoryCore platform
Description

All-in-one web-based myopia management platform combining patient communication, axial length estimation, and clinical scoring tools to help eyecare professionals manage childhood myopia; built on a database of over one million patient records.

2mEYE Guide
CategoryPatient communication software
Description

Patient communication tool that creates personalized myopia management reports for children, designed for parents and accessible via QR code or link sharing from any browser; available on monthly or annual subscription.

3mEYE Gauge
CategoryClinical decision support software
Description

Axial length estimation tool for clinicians without access to biometry, delivering data-driven estimates with a 95% prediction range and comparing the child's measurements to age- and sex-matched reference values.

4mEYE Score
CategoryClinical decision support software
Description

Treatment monitoring module that provides engaging, data-driven visuals for eyecare professionals and parents to track ongoing myopia management outcomes.

5Ocumetra API
CategoryIntegration API
Description

API that enables EHR/EMR software providers and biometric device manufacturers to embed Ocumetra's myopia control analytics and communication tools within their own platforms, built for compatibility and security.

6Partnership Program Services
CategoryPartnership services
Description

Bespoke services covering custom clinical tools, data analytics, and integration delivery for industry partners (e.g. contact lens, pharmaceutical, eyecare product companies), academic institutions, and integration partners; revenue generated through bespoke partnership agreements.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeTechnology or Integration
Description

Topcon Healthcare is listed as an integration partner, collaborating on API integration of Ocumetra's myopia control analytics with Topcon's eye care technology platforms. The partnership enables seamless data exchange and enhanced clinical workflows for eyecare professionals using Topcon devices.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leo MacCanna, CEO and founder of Ocuco (optical software company), serves on Ocumetra's Board of Directors, bringing extensive expertise in IT strategy and optical software. Ocuco has a proven track record in scaling businesses internationally in the optical/eye care software space.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Network of clinical partners including Duncan Todd Opticians, FYidoctors, Hakin Group, Myopia Focus, Lynne Fernandes Optometrists, Abesami Eye, PODS, Feltham Eyecare, and others using Ocumetra tools to enhance their myopia management services. These practices serve as reference customers and channel advocates.

4Industry Partners (Eyecare Product Companies)
Strategic tierStrategicTypeGTM or Marketing Partner
Description

Partnerships with eyecare product companies including Dopavision, Copper Vision, Sightglass, and Safilens. These partners use Ocumetra's data analytics and marketing tools to increase product sales, engage parents and clinicians, and understand real-world treatment efficacy of their myopia management products.

ocumetra.com
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Partnerships with universities including University of Bradford, University of Alabama, Ferris State University, Nova Southeastern University, Western Health, Massachusetts College of Optometry, Technological University Dublin. These institutions provide free platform access to students for educational purposes and collaborate on research.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Gareth Lingham, Clinical Data Analyst at Ocumetra, is also a postdoctoral research fellow at the Lions Eye Institute in Perth, Australia. This academic connection supports research collaboration on myopia management and outdoor activity benefits.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Essilor's Stellest lens competes in the myopia management category alongside clinical support resources for prescribing ECPs. As a global optical incumbent, Essilor represents both a potential partner and a competitor with overlapping practitioner-facing software ambitions.

TypeBroad incumbent
Description

CooperVision manufactures MiSight contact lenses for myopia management and provides clinical resources and digital tools to ECPs. As a partner using Ocumetra's analytics to support its MiSight franchise, CooperVision is a broad incumbent with overlapping patient communication and outcome-tracking capabilities.

TypeOthers
Description

VisionWeb provides practice management, electronic claims, and supplier connectivity solutions to the optical industry. It serves the same optometry and optical retail customer base, making it an adjacent ecosystem participant rather than a direct myopia analytics competitor.

TypeDirect peer
Description

Treehouse Eyes operates a US-based network of myopia management clinics with proprietary clinical protocols and parent education tools. While service-led rather than software-led, it competes directly for the same ECP and parent attention around myopia management.

TypeBroad incumbent
Description

Bausch + Lomb offers myopia management contact lenses (including Bausch + Lomb Arise) and provides clinical education and digital resources to optometrists. It is a broad incumbent in the same clinical workflow as Ocumetra's mEYE Suite.

6RevolutionEHR
TypeOthers
Description

RevolutionEHR is an electronic health record platform built specifically for optometry practices. As a complementary/adjoining technology rather than a direct competitor, it is a potential integration partner in the same ECP workflow Ocumetra targets.

TypeEmerging player
Description

Myopia Profile is a clinical education and digital resources platform for eye care professionals managing myopia. It addresses an overlapping audience of ECPs with content, courses, and clinical tools, partially competing with Ocumetra's practitioner-facing value.

TypeDirect peer
Description

Ocuco provides practice management software and EHR platforms for the optical industry. It is Ocumetra's closest software peer, sharing the same customer base of optometrists and optical retailers; Ocuco's CEO Leo MacCanna also sits on Ocumetra's board, signaling ecosystem proximity.

TypeBroad incumbent
Description

Topcon is a global ophthalmic device and software company whose products (biometers, OCTs, EHR) intersect with Ocumetra's clinical workflows. Topcon is both an integration partner and a board-level investor (via THINC Ventures), positioning it as a broad incumbent collaborating in the same clinical category.

TypeBroad incumbent
Description

HOYA's MiyoSmart spectacle lens is one of the leading myopia management products globally. HOYA provides clinical support tools and educational content to ECPs, overlapping with Ocumetra's parent-communication and treatment-monitoring value proposition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles23 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ocumetra

Myopia Management Softwareocumetra.com

Ocumetra is a Dublin-based digital health company that provides the mEYE Suite, a web-based myopia management software platform serving eyecare professionals, optical networks, and eyecare product companies with predictive analytics, parent communication tools, and EHR/biometric device integrations.

What Ocumetra does

Ocumetra is a Dublin-based digital health company that develops the mEYE Suite, a web-based software platform for evidence-based myopia management in children. The platform is built around a proprietary, population-representative database of over one million data points on refractive development, axial length, and myopia-related disease risk, accumulated over eight years and incorporating multi-ethnic data. Core products include mEYE Guide (parent-facing communication reports with QR sharing), mEYE Gauge (axial length estimation with a 95% prediction range for clinicians without biometry equipment), mEYE Score (treatment monitoring), and the forthcoming mEYE Map. An API enables integration with EHR/EMR systems and biometric devices, with Topcon Healthcare named as an integration partner. The platform is web-based, GDPR-compliant, ISO 27001:2022 certified, and available in seven languages across markets including Ireland, the UK, North America, Australia, and New Zealand.

Ocumetra generates revenue primarily through recurring subscriptions to mEYE Suite, sold on monthly or annual cycles with a one-month free trial and tiered pricing for independent practices (1-4 clinics), growing groups (5-15), networks (15-50), and large enterprises (50+ clinics). A second revenue stream comes from bespoke industry solutions and data analytics services provided to eyecare product companies such as CooperVision, Dopavision, Sightglass, and Safilens, including clinical trial support and marketing tools. Academic partnerships offer free platform access to optometry/ophthalmology students at universities including TU Dublin, University of Bradford, and Nova Southeastern, serving as a long-term adoption pipeline. Go-to-market combines product-led growth (self-serve trial, multi-language web platform) with channel partnerships through a structured four-track program spanning clinical, industry, academic, and integration partners.

The company is co-founded and led by Professor James Loughman (CEO, PhD) and Professor Ian Flitcroft (CIO, D.Phil FRCOphth), both recognized myopia researchers, supported by a management team with regulatory, software development, clinical data analysis, and strategic growth functions. The board includes representatives from Ocuco, Furthr VC, and THINC Ventures (Topcon Healthcare's CVC), reflecting a mix of strategic corporate and venture capital backing. Headcount is reported at 11-50 employees.

Ocumetra firmographics

Firmographics
Name
Ocumetra
Legal name
Ocumetra Ltd.
Website
https://ocumetra.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Ocumetra is a Dublin-based digital health company that provides the mEYE Suite, a web-based myopia management software platform serving eyecare professionals, optical networks, and eyecare product companies with predictive analytics, parent communication tools, and EHR/biometric device integrations.
Ownership category
akta.pro rank

Where Ocumetra is headquartered

Location

Headquarters

HQ city
Dublin
HQ country
Ireland
HQ region
Europe

Offices2 records

Markets served

Ocumetra business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Software Subscription (mEYE Guide): Monthly or annual subscription service for mEYE Guide patient communication platform. Free 1-month trial available. Annual subscription includes two months free (preferred option). Easily cancellable subscriptions. Revenue is subscription-based recurring with monthly or annual billing cycles.
  2. Bundled Platform Access: Annual bundle offering provides access to multiple tools (mEYE Guide, mEYE Gauge) with two months free, offering better value than monthly subscriptions. mEYE Gauge is included free with mEYE Guide subscription.
  3. Bespoke Industry Solutions: Custom clinical tools, data analytics, and integration services for industry partners seeking to enhance myopia management outcomes. Revenue generated through bespoke partnership agreements with product companies requiring custom tools including myopia and presbyopia simulation tools.
  4. Enterprise/Group Subscriptions: Tiered subscription models targeting different practice sizes from independent innovators (1-4 clinics) to energetic enterprises (50+ clinics), with pricing varying by organization scale. Payments processed via Stripe supporting credit cards, debit cards, digital wallets, and regional payment methods.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree 1-month trial with access to mEYE Guide and mEYE Gauge
SubscriptionMonthlyMonthly subscription after free trial
SubscriptionAnnualAnnual bundle subscription with 2 months free

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Ocumetra product offering

Product offering

Core offering

Ocumetra sells the mEYE Suite, a web-based myopia management software platform for eyecare professionals that combines parent communication tools, axial length estimation, treatment monitoring, and centile-based clinical scoring, powered by a proprietary database of over one million patient records and machine learning-based predictive modeling. The company also offers an API for EHR/EMR and biometric device integration and a partnership program delivering bespoke clinical tools, data analytics, and integration services to industry, academic, and clinical partners.

Product overview

Ocumetra offers the mEYE Suite as its core all-in-one myopia management software platform. The suite consists of interconnected modules: mEYE Guide for parent communication, mEYE Gauge for axial length estimation (free with Guide subscription), mEYE Score for treatment monitoring, and the forthcoming mEYE Map for refractive context. Additional tools include centile charts and a vision simulator. The platform is web-based and accessible on any modern browser (phone, tablet, or desktop), available globally in English, French, Spanish, Portuguese, Hebrew, Russian, and Italian. Ocumetra also provides an API for EHR/EMR and biometric device integrations, alongside a partnership program offering bespoke clinical tools, data analytics, and integration services for clinical, industry, integration, and academic partners.

Differentiator

Problem solved

Functional benefit

Brands

  • mEYE Suite: An all-in-one myopia management software platform featuring modules for patient communication, axial length estimation, and clinical scoring.
  • mEYE Guide
  • mEYE Gauge
  • mEYE Score
  • mEYE Map

Products and services

  • mEYE Suite All-in-one web-based myopia management platform combining patient communication, axial length estimation, and clinical scoring tools to help eyecare professionals manage childhood myopia; built on a database of over one million patient records.
  • mEYE Guide Patient communication tool that creates personalized myopia management reports for children, designed for parents and accessible via QR code or link sharing from any browser; available on monthly or annual subscription.
  • mEYE Gauge Axial length estimation tool for clinicians without access to biometry, delivering data-driven estimates with a 95% prediction range and comparing the child's measurements to age- and sex-matched reference values.
  • mEYE Score Treatment monitoring module that provides engaging, data-driven visuals for eyecare professionals and parents to track ongoing myopia management outcomes.
  • Ocumetra API API that enables EHR/EMR software providers and biometric device manufacturers to embed Ocumetra's myopia control analytics and communication tools within their own platforms, built for compatibility and security.
  • Partnership Program Services Bespoke services covering custom clinical tools, data analytics, and integration delivery for industry partners (e.g. contact lens, pharmaceutical, eyecare product companies), academic institutions, and integration partners; revenue generated through bespoke partnership agreements.

Quantifiable outcome

  • 75% average increase in myopia management treatment uptake and retention in practices using Ocumetra tools
  • +3 more outcomes

Companies that use Ocumetra

Customer profile

Named customers6 records

Segments7 records

Ideal customer profiles4 records

Ocumetra technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability5 records

Feature7 records

Ocumetra partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and strategic.

  • Topcon HealthcarecoreTechnology or IntegrationTopcon Healthcare is listed as an integration partner, collaborating on API integration of Ocumetra's myopia control analytics with Topcon's eye care technology platforms. The partnership enables seamless data exchange and enhanced clinical workflows for eyecare professionals using Topcon devices.
  • OcucocoreStrategic or Co-development PartnerLeo MacCanna, CEO and founder of Ocuco (optical software company), serves on Ocumetra's Board of Directors, bringing extensive expertise in IT strategy and optical software. Ocuco has a proven track record in scaling businesses internationally in the optical/eye care software space.
  • Clinical Partners NetworkcoreChannel Partner/ Reseller/ DistributorNetwork of clinical partners including Duncan Todd Opticians, FYidoctors, Hakin Group, Myopia Focus, Lynne Fernandes Optometrists, Abesami Eye, PODS, Feltham Eyecare, and others using Ocumetra tools to enhance their myopia management services. These practices serve as reference customers and channel advocates.
  • Industry Partners (Eyecare Product Companies)strategicGTM or Marketing PartnerPartnerships with eyecare product companies including Dopavision, Copper Vision, Sightglass, and Safilens. These partners use Ocumetra's data analytics and marketing tools to increase product sales, engage parents and clinicians, and understand real-world treatment efficacy of their myopia management products.
  • Academic PartnersstrategicStrategic or Co-development PartnerPartnerships with universities including University of Bradford, University of Alabama, Ferris State University, Nova Southeastern University, Western Health, Massachusetts College of Optometry, Technological University Dublin. These institutions provide free platform access to students for educational purposes and collaborate on research.
  • Lions Eye InstitutestrategicStrategic or Co-development PartnerGareth Lingham, Clinical Data Analyst at Ocumetra, is also a postdoctoral research fellow at the Lions Eye Institute in Perth, Australia. This academic connection supports research collaboration on myopia management and outdoor activity benefits.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Ocumetra competitors and assessment

Company assessment

Broad incumbents

  • Essilor (EssilorLuxottica): Essilor's Stellest lens competes in the myopia management category alongside clinical support resources for prescribing ECPs. As a global optical incumbent, Essilor represents both a potential partner and a competitor with overlapping practitioner-facing software ambitions.
  • CooperVision: CooperVision manufactures MiSight contact lenses for myopia management and provides clinical resources and digital tools to ECPs. As a partner using Ocumetra's analytics to support its MiSight franchise, CooperVision is a broad incumbent with overlapping patient communication and outcome-tracking capabilities.
  • Bausch + Lomb: Bausch + Lomb offers myopia management contact lenses (including Bausch + Lomb Arise) and provides clinical education and digital resources to optometrists. It is a broad incumbent in the same clinical workflow as Ocumetra's mEYE Suite.
  • Topcon Healthcare: Topcon is a global ophthalmic device and software company whose products (biometers, OCTs, EHR) intersect with Ocumetra's clinical workflows. Topcon is both an integration partner and a board-level investor (via THINC Ventures), positioning it as a broad incumbent collaborating in the same clinical category.
  • HOYA: HOYA's MiyoSmart spectacle lens is one of the leading myopia management products globally. HOYA provides clinical support tools and educational content to ECPs, overlapping with Ocumetra's parent-communication and treatment-monitoring value proposition.

Others

  • VisionWeb: VisionWeb provides practice management, electronic claims, and supplier connectivity solutions to the optical industry. It serves the same optometry and optical retail customer base, making it an adjacent ecosystem participant rather than a direct myopia analytics competitor.
  • RevolutionEHR: RevolutionEHR is an electronic health record platform built specifically for optometry practices. As a complementary/adjoining technology rather than a direct competitor, it is a potential integration partner in the same ECP workflow Ocumetra targets.

Direct peers

  • Treehouse Eyes: Treehouse Eyes operates a US-based network of myopia management clinics with proprietary clinical protocols and parent education tools. While service-led rather than software-led, it competes directly for the same ECP and parent attention around myopia management.
  • Ocuco: Ocuco provides practice management software and EHR platforms for the optical industry. It is Ocumetra's closest software peer, sharing the same customer base of optometrists and optical retailers; Ocuco's CEO Leo MacCanna also sits on Ocumetra's board, signaling ecosystem proximity.

Emerging players

  • Myopia Profile: Myopia Profile is a clinical education and digital resources platform for eye care professionals managing myopia. It addresses an overlapping audience of ECPs with content, courses, and clinical tools, partially competing with Ocumetra's practitioner-facing value.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Ocumetra social profiles

Digital presence

Ocumetra compliance and trust

Trust signal

Compliance2 records

Ocumetra financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ocumetra leadership team

Management profile

Number of profiles

Profiles23 records

Ocumetra funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ocumetra M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ocumetra

What does Ocumetra do?

Ocumetra sells the mEYE Suite, a web-based myopia management software platform for eyecare professionals that combines parent communication tools, axial length estimation, treatment monitoring, and centile-based clinical scoring, powered by a proprietary database of over one million patient records and machine learning-based predictive modeling. The company also offers an API for EHR/EMR and biometric device integration and a partnership program delivering bespoke clinical tools, data analytics, and integration services to industry, academic, and clinical partners.

Is Ocumetra a public or private company?

Ocumetra is a private company. It is classified as venture growth investor backed and is currently operating.

When was Ocumetra founded?

Ocumetra was founded in 2021. It employs 11 to 50 people.

Where is Ocumetra based?

Ocumetra is headquartered in Dublin, Ireland, in the Europe region.

How does Ocumetra make money?

Four revenue lines are on record. Software Subscription (mEYE Guide) is the primary driver. The others are bundled Platform Access, bespoke Industry Solutions and enterprise/Group Subscriptions.

Who are Ocumetra's main competitors?

Broad incumbents on record are Essilor (EssilorLuxottica), CooperVision, Bausch + Lomb, Topcon Healthcare and HOYA. Others are VisionWeb and RevolutionEHR. Direct peers are Treehouse Eyes and Ocuco. Myopia Profile is listed as an emerging player.

Does Ocumetra have an API?

Yes. Ocumetra offers an API that integrates with devices, EHR/EMR systems and platforms. The API is described as built for compatibility and designed for security. It enables EHR/EMR software and biometric device integrations, allowing eye care professionals to incorporate Ocumetra's myopia control analytics and communication tools into their existing workflows.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
OcumetraPartnership Program – OcumetraOcumetra is promoting its partnership program designed to advance global eye care through open innovation and collaboration with various stakeholders. The company offers bespoke solutions including clinical tools, data analytics, and integration services to enhance myopia management outcomes for patients and practitioners.Eyes On EyecareOcumetra showcases all-in-one myopia management softwareOcumetra introduced the mEYE Suite, an all-in-one myopia management software platform, at Vision Expo East in Orlando. The web-based tool utilizes a database of over one million patient records and features modules for patient communication, axial length estimation, and clinical scoring to assist eyecare professionals. Recent user data indicates that adoption of the platform led to significant increases in treatment uptake and clinician confidence while reducing chair time.Daily Medical NewsOcumetra, Topcon partner to expand digital health care solutions for myopia managementOcumetra and Topcon Healthcare partnered to integrate Ocumetra's myopia management platform with Topcon's cloud-based Harmony digital health platform. The collaboration aims to provide evidence-based clinical support and data-driven insights for eye care professionals, improving access to resources for identifying and treating children at risk of progressive myopia.Daily Medical NewsOcumetra launches products to help clinicians manage myopiaOcumetra launched mEYE Guide and mEYE Gauge in January at Vision Expo East to help clinicians manage myopia. The products address barriers like education and confidence, with mEYE Gauge estimating axial length within ±0.5 mm. Pending regulatory approval, the platform will add treatment monitoring tools.